Asset sale Announced
HealthCare Royalty acquisition of Modeyso commercial sales royalties
Announced Apr 2026
Advisers
Modeyso commercial sales royalties
Target
- Legal adviser
HealthCare Royalty
Acquirer
Not disclosed
- Target
- Modeyso commercial sales royalties
- Acquirer
- HealthCare Royalty
- Seller
- Former Oncoceutics Inc. securityholders
- Target based in
- United States (unverified)
- Buyer based in
- United States
- Seller based in
- United States (unverified)
- Sector
- Specialty finance and leasing
- Tags
- Specialty finance and leasing, Pharma, Biotech, Oncology
In the league tables
Similar deals
- Servier acquisition of Day One Biopharmaceuticals Mar 2026 · US$2.5bn · Biotech
- Fresenius acquisition of mAbxience Oct 2026 · US$1.9bn · Biotech
- US WorldMeds acquisition of Orbus Therapeutics Oct 2026 · Pharma
- DRI Healthcare Trust acquisition of Royalty participation rights in U.S. net sales of tavapadon Sep 2026 · US$316m · Specialty finance and leasing
- Grünenthal acquisition of Stivarga (regorafenib) Sep 2026 · US$433m · Pharma
